The North America Head And Neck Cancer Therapeutics Market would witness market growth of 11.2% CAGR during the forecast period (2022-2028).
A record of tobacco consumption or contact with the human papillomavirus is frequently linked to squamous cell carcinoma (HPV). In addition to salivary gland tumors, lymphomas, and sarcomas, there are a few less frequent kinds of head and neck cancer. In addition to preventing the consumption of alcohol and cigarette products, children and young people can be vaccinated against HPV.
There are four primary modes of cancer's spread, the first is the direct expansion of the core location to neighboring places. The second is transmitted to lymph nodes through lymphatic pathways. The third kind spreads via nerves to various parts of the head and neck (perineural spread). The fourth is distributed throughout the body via the blood vessels.
It is typical for head and neck cancer to move to the lymph nodes in the neck. The lymph nodes that are most frequently affected depend on the origin of the main tumor. The majority of lymph nodes are situated along major blood veins under the sternocleidomastoid muscle on both sides of the neck.
In the United States, roughly 4% of all malignancies are head and neck cancers. These malignancies are more than double as prevalent in males as in women. Head and neck cancers are also detected more frequently in those over 50 than in those under 50. It is anticipated that even more than 68,000 men and women will be diagnosed with head and neck malignancies in the United States in 2021. The majority will be diagnosed with cancer of the mouth, throat, or voice box.
The US market dominated the North America Head & Neck Cancer Therapeutics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $743.3 Million by 2028. The Canada market is poised to grow at a CAGR of 13.3% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 13% during (2022 - 2028).
Based on Therapy Type, the market is segmented into Immunotherapy, Chemotherapy, and Targeted Therapy. Based on Route of Administration, the market is segmented into Injectable and Oral. Based on Distribution Channel, the market is segmented into Retail & Specialty Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Head And Neck Cancer Therapeutics Market is Predict to reach $2.5 Billion by 2028, at a CAGR of 12.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eli Lilly and Company, Merck & Co., Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Teva Pharmaceuticals Industries Ltd., F. Hoffmann-La Roche Ltd., AstraZeneca Plc, Bristol Myers Squibb Company, and Clinigen Group PLC.
Scope of the Study
Market Segments Covered in the Report:
By Therapy Type
- Immunotherapy
- Chemotherapy
- Targeted Therapy
By Route of Administration
By Distribution Channel
- Retail & Specialty Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Eli Lilly and Company
- Merck & Co., Inc.
- Sanofi S.A.
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceuticals Industries Ltd.
- F. Hoffmann-La Roche Ltd.
- AstraZeneca Plc
- Bristol Myers Squibb Company
- Clinigen Group PLC
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Head & Neck Cancer Therapeutics Market, by Therapy Type
1.4.2 North America Head & Neck Cancer Therapeutics Market, by Route of Administration
1.4.3 North America Head & Neck Cancer Therapeutics Market, by Distribution Channel
1.4.4 North America Head & Neck Cancer Therapeutics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Head And Neck Cancer Therapeutics Market
Chapter 4. North America Head & Neck Cancer Therapeutics Market by Therapy Type
4.1 North America Immunotherapy Market by Country
4.2 North America Chemotherapy Market by Country
4.3 North America Targeted Therapy Market by Country
Chapter 5. North America Head & Neck Cancer Therapeutics Market by Route of Administration
5.1 North America Injectable Market by Country
5.2 North America Oral Market by Country
Chapter 6. North America Head & Neck Cancer Therapeutics Market by Distribution Channel
6.1 North America Retail & Specialty Pharmacies Market by Country
6.2 North America Hospital Pharmacies Market by Country
6.3 North America Online Pharmacies Market by Country
Chapter 7. North America Head & Neck Cancer Therapeutics Market by Country
7.1 US Head & Neck Cancer Therapeutics Market
7.1.1 US Head & Neck Cancer Therapeutics Market by Therapy Type
7.1.2 US Head & Neck Cancer Therapeutics Market by Route of Administration
7.1.3 US Head & Neck Cancer Therapeutics Market by Distribution Channel
7.2 Canada Head & Neck Cancer Therapeutics Market
7.2.1 Canada Head & Neck Cancer Therapeutics Market by Therapy Type
7.2.2 Canada Head & Neck Cancer Therapeutics Market by Route of Administration
7.2.3 Canada Head & Neck Cancer Therapeutics Market by Distribution Channel
7.3 Mexico Head & Neck Cancer Therapeutics Market
7.3.1 Mexico Head & Neck Cancer Therapeutics Market by Therapy Type
7.3.2 Mexico Head & Neck Cancer Therapeutics Market by Route of Administration
7.3.3 Mexico Head & Neck Cancer Therapeutics Market by Distribution Channel
7.4 Rest of North America Head & Neck Cancer Therapeutics Market
7.4.1 Rest of North America Head & Neck Cancer Therapeutics Market by Therapy Type
7.4.2 Rest of North America Head & Neck Cancer Therapeutics Market by Route of Administration
7.4.3 Rest of North America Head & Neck Cancer Therapeutics Market by Distribution Channel
Chapter 8. Company Profiles
8.1 Eli Lilly And Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.2 Merck & Co., Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Sanofi S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Takeda Pharmaceutical Company Limited
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.4.5.2 Geographical Expansions:
8.5 Teva Pharmaceutical Industries Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 F. Hoffmann-La Roche Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 AstraZeneca PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.8 Bristol Myers Squibb Company
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Clinigen Group PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
TABLE 1 North America Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 2 North America Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 3 North America Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 4 North America Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 5 North America Immunotherapy Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Immunotherapy Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Chemotherapy Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Chemotherapy Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Targeted Therapy Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Targeted Therapy Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 12 North America Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 13 North America Injectable Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Injectable Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Oral Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Oral Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 18 North America Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 19 North America Retail & Specialty Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Retail & Specialty Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 21 North America Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Online Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Online Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Head & Neck Cancer Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Head & Neck Cancer Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 27 US Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 28 US Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 29 US Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 30 US Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 31 US Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 32 US Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 33 US Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 34 US Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 35 Canada Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 36 Canada Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 37 Canada Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 38 Canada Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 39 Canada Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 40 Canada Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 41 Canada Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 42 Canada Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 43 Mexico Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 44 Mexico Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 45 Mexico Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 46 Mexico Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 47 Mexico Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 48 Mexico Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 49 Mexico Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 50 Mexico Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 51 Rest of North America Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 52 Rest of North America Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 53 Rest of North America Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 54 Rest of North America Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 55 Rest of North America Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 56 Rest of North America Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 57 Rest of North America Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 58 Rest of North America Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 59 Key Information – Eli Lilly And Company
TABLE 60 KEY INFORMATION - MERCK & CO., INC.
TABLE 61 Key Information – Sanofi S.A.
TABLE 62 Key Information – Takeda Pharmaceutical Company Limited
TABLE 63 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 64 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 65 KEY INFORMATION – AstraZeneca PLC
TABLE 66 Key Information – Bristol Myers Squibb Company
TABLE 67 Key Information – Clinigen Group PLC
List of Figures
FIG 1 Methodology for the research